Second Sight Medical Products, Inc. Warrants expiring 03/14/2024

$0.2219
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0315 (+16.54%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can watch EYESW and buy or sell other stocks, options, and ETFs commission-free!

About EYESW

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It operates through the following geographical segments: United States, Italy, France, and China. The firm's product include Argus II Retinal Prosthesis System that treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA. The listed name for EYESW is Second Sight Medical Products, Inc. Warrants expiring 03/14/2024.

CEO
Matthew J. Pfeffer, CPA
Employees
—
Headquarters
Sylmar, California
Founded
1998
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
84.09K
High Today
$0.29
Low Today
$0.18
Open Price
$0.20
Volume
123.71K
52 Week High
$1.50
52 Week Low
$0.0254

Collections

You May Also Like

OPRA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure